Oprozomib (OPZ) and Dexamethasone (DEX) in Patients (Pts) With Relapsed and/or Refractory Multiple Myeloma (RRMM): Updated Results From a Phase 1b/2, Multicenter, Open-Label Study

Claudia Prada, Parameswaran Hari, Peter M. Voorhees et al.|Clinical Lymphoma Myeloma & Leukemia|2015

Cited by 5